48 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthetic 1,2,3-triazole-linked glycoconjugates bind with high affinity to human galectin-3.

Fcfrp - Usp
Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.

Lund University
Elements and modulation of functional dynamics.

Janssen Research and Development
Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.

Utrecht University
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.

The Hashemite University
Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.

Lund University
Synthesis of stable and selective inhibitors of human galectins-1 and -3.

University of Montreal
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.

Lund University
Synthesis and galectin-binding activities of mercaptododecyl glycosides containing a terminalß-galactosyl group.

National Institute of Advanced Industrial Science and Technology (Aist)
Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.

Lund University
Discovery of

Peking Union Medical College
Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds.

Lund University
Strong Binding of

University of Debrecen
Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3.

University of Maryland
Discovery of Selective and Orally Available Galectin-1 Inhibitors.

Galecto Biotech
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for drug design.

Bristol Myers Squibb
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.

Griffith University
Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.

Bristol Myers Squibb
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.

Galecto Biotech
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors.

Bristol Myers Squibb
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.

Lund University
Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain.

Lund University
Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

Stanford University School of Medicine
Novel Galectin-3 Inhibitors for Treating Fibrosis.

Smith, Gambrell & Russell
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.

Institute of Science Education and Research-Kolkata (Iiser) Kolkata
Epimers Switch Galectin-9 Domain Selectivity: 3

Lund University
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.

University of Sao Paulo
Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance.

Ludwig-Maximilians-University Munich
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.

Lund University
NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF

Jacobio Pharmaceuticals
INHIBITORS OF METTL3

Strom Therapeutics
Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament

China Pharmaceutical University
MODULATORS OF ALPHA-1 ANTITRYPSIN

Vertex Pharmaceuticals
INDAZOLE DERIVATIVES AS INHIBITORS OF SARM1

Disarm Therapeutics
Tricyclic amine compounds as CDK2 inhibitors

Incyte
Pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer

Pelemed
1,8-naphthyridinone compounds and uses thereof

Nuvation Bio
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Ideaya Biosciences
2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthma

DompÉ
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

Aclaris Therapeutics
Bicyclic compounds as ATX inhibitors

Hoffmann-La Roche
Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders

Northwestern University
CXCR4 inhibitors and uses thereof

X4 Pharmaceuticals
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof

Pharmaxis
Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives

Pfizer
Inhibitors of PDE10

Bristol-Myers Squibb
Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.

Burnham Institute